Christopher Hite

Insider Reports History

Entity
Individual
Location
C/O Acceleron Pharma Inc., 128 Sidney Street, Cambridge, MA
Signature
/s/ Jason Mehar, as Attorney-in-Fact for Christopher Hite
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Hite:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc EVP & Vice Chairman Class A Ordinary Shares 370K $11.2M $30.23 May 13, 2024 By SCH Investment Partners LLC
Royalty Pharma plc EVP & Vice Chairman LP interests in RPI US Partners 2019, LP 541 May 13, 2024 By SCH Investment Partners LLC
ACCELERON PHARMA INC Director Common Stock 0 $29.37 Nov 19, 2021 Direct
ACCELERON PHARMA INC Director Option to Purchase Common Stock 0 Nov 19, 2021 Direct

Insider Reports Filed by Christopher Hite

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPRX Royalty Pharma plc May 13, 2024 2 $0 4 May 16, 2024 EVP & Vice Chairman
XLRN ACCELERON PHARMA INC Nov 19, 2021 3 $0 4 Nov 22, 2021 Director